NASDAQ:PLRX

Pliant Therapeutics Stock Forecast

etoro logo Buy PLRX
*Your capital is at risk
$1.13
-0.0100 (-0.88%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of PLRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PLRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Pliant Therapeutics Inc. stock after losing 0.88%
(Updated on Jun 12, 2026)

Sell candidate since Jun 01, 2026 Loss -5.83%

The Pliant Therapeutics Inc. stock price fell by -0.88% on the last day (Friday, 12th Jun 2026) from $1.14 to $1.13. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.54% from a day low at $1.13 to a day high of $1.17. The price has fallen in 7 of the last 10 days and is down by -10.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -285 thousand shares and in total, 207 thousand shares were bought and sold for approximately $233.99 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.52% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.10 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PLRX Signals & Forecast

There are few to no technical positive signals at the moment. The Pliant Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.16 and $1.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 08, 2026, and so far it has fallen -16.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Pliant Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 3.54%. For the last week the stock has had daily average volatility of 4.50%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PLRX) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Pliant Therapeutics Inc. to open at $1.14, and during the day (based on 14 day Average True Range), to move between $1.10 and $1.16, which gives a possible trading interval of +/-$0.0519 (+/-4.70%) up or down from last closing price. If Pliant Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.70% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.18, some $0.0500 (4.42%) from the current price of $1.13, our system finds the risk reward not very attractive.

Is Pliant Therapeutics Inc. stock A Buy?

Pliant Therapeutics Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.769 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $1.14 ( 1.18%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PLRX Performance

Trading levels for PLRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.18 4.72%
R2 1.17 3.37%
R1 1.16 2.53%
Price 1.13
S1 1.13 -0.172%
S2 1.12 -1.01%
S3 1.10 -2.36%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.29 14.16%
R2 1.20 6.19%
R1 1.18 4.42%
Price 1.13
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Pliant Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Pliant Therapeutics Inc. is PLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pliant Therapeutics Inc. Stock.

What's the current price of Pliant Therapeutics Inc. Stock?
As of the end of day on the Jun 12, 2026, the price of an Pliant Therapeutics Inc. (PLRX) share was $1.13.

What is the 52-week high and low for Pliant Therapeutics Inc. Stock?
The 52-week high for Pliant Therapeutics Inc. Stock is $1.95 and the 52-week low is $1.09.

What is the market capitalization of Pliant Therapeutics Inc. Stock?
As of the Jun 12, 2026, the market capitalization of Pliant Therapeutics Inc. is 69.97M.

When is the next earnings date for Pliant Therapeutics Inc.?
The upcoming earnings date for Pliant Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT PLIANT THERAPEUTICS INC.
Pliant Therapeutics
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which complet...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE